期刊
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 134, 期 48, 页码 19782-19787出版社
AMER CHEMICAL SOC
DOI: 10.1021/ja3084708
关键词
-
资金
- NIH [GM-073855]
- NIGMS CMLD Initiative [P50 GM067041]
- Intramural Research Program of NIH, National Cancer Institute, Center for Cancer Research
- Developmental Therapeutics Program, Division of Cancer Diagnosis and Treatment
- Vertex Pharmaceuticals, Inc.
A rhodium-catalyzed dehydrogenation protocol for the conversion of 3,5-diarylcyclopentenones to the corresponding 2,4-diarylcyclopentadienones has been developed. With this protocol, analogues of the cytotoxic agent chamaecypanone C have been synthesized via Diels-Alder cycloaddition between the cyclopentadienones and in situ-generated o-quinols. Biological evaluation of these analogues revealed a compound with higher activity as a microtubule inhibitor and cytotoxic agent in comparison with the parent structure.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据